Merck is to buy rival Schering-Plough in a $41.1bn (£29.4bn) deal, creating one of the world's biggest pharmaceutical companies.The merger unites the makers of cholesterol drugs Zetia and Vytorin at a time of falling sales.
The deal follows Pfizer's $68bn takeover of Wyeth, unveiled in January.
BBC
